End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 GBX | 0.00% | 0.00% | +48.39% |
May. 17 | Braveheart writes down value of two investments | AN |
Apr. 09 | Fenikso receives partial repayment regarding 2022 USD43.5 million loan | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|---|
Capitalization 1 | 117.7 | 52.95 | 33.08 | 6.904 | 4.803 |
Enterprise Value (EV) 1 | 140.3 | 63.01 | 49.55 | 6.854 | 14.01 |
P/E ratio | 22.9 x | -4.93 x | -2.86 x | -0.03 x | -0.43 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 3.82 x | 1.09 x | 0.79 x | - | - |
EV / Revenue | 4.55 x | 1.29 x | 1.18 x | - | - |
EV / EBITDA | -24.1 x | 5.04 x | 6.64 x | -0.06 x | - |
EV / FCF | -58.4 x | 2.9 x | 3.06 x | -0.02 x | -1.33 x |
FCF Yield | -1.71% | 34.5% | 32.7% | -4,502% | -75.3% |
Price to Book | 0.56 x | 0.28 x | 0.19 x | 0.05 x | 0.27 x |
Nbr of stocks (in thousands) | 536,530 | 536,530 | 536,530 | 536,530 | 536,780 |
Reference price 2 | 0.2194 | 0.0987 | 0.0617 | 0.0129 | 0.008948 |
Announcement Date | 6/4/18 | 6/19/19 | 8/26/20 | 6/30/22 | 6/6/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|---|
Net sales 1 | 30.85 | 48.69 | 42.03 | - | - |
EBITDA 1 | -5.818 | 12.51 | 7.459 | -114.1 | - |
EBIT 1 | -14.07 | 2.207 | -1.276 | -232.8 | -15.4 |
Operating Margin | -45.6% | 4.53% | -3.04% | - | - |
Earnings before Tax (EBT) 1 | -14.84 | 2.294 | -4.915 | -237.2 | -15.4 |
Net income 1 | 5.15 | -7.924 | -11.58 | -237.2 | -15.4 |
Net margin | 16.69% | -16.28% | -27.55% | - | - |
EPS 2 | 0.009598 | -0.0200 | -0.0216 | -0.4418 | -0.0209 |
Free Cash Flow 1 | -2.402 | 21.73 | 16.21 | -308.6 | -10.55 |
FCF margin | -7.78% | 44.63% | 38.58% | - | - |
FCF Conversion (EBITDA) | - | 173.73% | 217.38% | - | - |
FCF Conversion (Net income) | - | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 6/4/18 | 6/19/19 | 8/26/20 | 6/30/22 | 6/6/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2021 | 2022 |
---|---|---|---|---|---|
Net Debt 1 | 22.6 | 10.1 | 16.5 | - | 9.21 |
Net Cash position 1 | - | - | - | 0.05 | - |
Leverage (Debt/EBITDA) | -3.882 x | 0.8046 x | 2.207 x | - | - |
Free Cash Flow 1 | -2.4 | 21.7 | 16.2 | -309 | -10.5 |
ROE (net income / shareholders' equity) | 3.22% | -3.98% | -6.69% | -251% | -57.3% |
ROA (Net income/ Total Assets) | -3.25% | 0.55% | -0.36% | -120% | -23.1% |
Assets 1 | -158.3 | -1,444 | 3,222 | 197.6 | 66.71 |
Book Value Per Share 2 | 0.3900 | 0.3500 | 0.3300 | 0.2500 | 0.0300 |
Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.0100 | 0 | 0 |
Capex 1 | 14 | 13.2 | 3.36 | - | - |
Capex / Sales | 45.3% | 27.18% | 8% | - | - |
Announcement Date | 6/4/18 | 6/19/19 | 8/26/20 | 6/30/22 | 6/6/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+48.39% | 7.23M | |
+5.76% | 291B | |
+1.02% | 137B | |
+50.92% | 124B | |
+20.56% | 81.83B | |
+1.92% | 70.84B | |
+3.75% | 54.93B | |
+5.02% | 46.49B | |
-10.08% | 35.16B | |
+24.75% | 34.5B |
- Stock Market
- Equities
- LEK Stock
- Financials Lekoil Limited